• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Primary Question and Hypothesis Testing in Randomized Controlled Clinical Trials

    2016-12-09 01:51:43JiangtaoLUO
    上海精神醫(yī)學(xué) 2016年3期
    關(guān)鍵詞:假設(shè)檢驗(yàn)樣本量臨床試驗(yàn)

    Jiangtao LUO

    ·Biostatistics in psychiatry (33)·

    Primary Question and Hypothesis Testing in Randomized Controlled Clinical Trials

    Jiangtao LUO

    hypothesis, randomize, clinical trial, primary question

    1. Primary and secondary questions

    Medical research is always about answering scientific questions related to treatments or preventions of diseases in special population of patients, who are defined by inclusion and exclusion criteria and treatments or preventions are performed among them.These questions are often divided into primary and secondary questions. Usually we have only one primary question in a study and it is the key and central question that we want to answer. We should state our primary question in advance rather than define it during our trial process later. Our study should be designed to answer the primary question and our sample size calculation should be based on it. It is unacceptable if a proposal lacks clear statement about primary question. Some research questions are important in public health and clinical practice, but we cannot answer them all due to limited technology and resources. So answerable is another criterion in choosing primary question.Therefore, at the design stage we must choose a primary question that we are able to answer via clinical trials.For example, in a study on ‘Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia’[1], the primary question is to find the treatment difference between ibrutinib and chlorambucil for ‘previously untreated older patients with CLL or small lymphocytic lymphoma’. All the other research questions are secondary.

    Secondary questions are closely related to the primary question. A study may have several secondary questions, which must be stated in advance or at design stage. We do not recommend mining data after the trial although data mining has become increasingly important in other settings. The number of secondary questions should be limited as well. Otherwise we may not have sufficient power to answer truly important questions and effectively control false positive rate. In Physicians’ Health Study[2], the primary question is total mortality rate between aspirin and placebo groups. The secondary question is fatal and nonfatal myocardial infarction.

    Once the primary question has been determined,the next step is to define the primary outcome that is used to describe the primary question. We must pay special attention to primary outcome and it must be evaluated in each of all study participants in the same way. Also the evaluation must be unbiased. Our recommendation is to use double blind, hard endpoint,and independent assessment. All study participants should have primary outcomes when the study ends[3,4].

    2. Hypothesis testing

    The methods for answering scientific questions from data collected in clinical trials belong to statistical inference. An important part of statistical inference is hypothesis testing, the foundation of which was laid by Fisher, Neyman, and Pearson among others[5]. Hypotheses consist of null hypothesis (H0)and alternative hypothesis (H1). The H1is our scientific hypothesis, which is what we want to collect data for.To test if H1is true, we start from H0, our straw man,since we usually already know from our pilot data,animal model or other approaches that H1is true. So we assume that H0is true and show that the probability that the observed data satisfies the null H0is very small (<0.05, usually). Thus, the null H0is opposite to the scientific hypothesis, the alternative H1, such as H0: cure rate for the standard therapy is equivalent to that for the experimental intervention vs. H1: cure rate for the standard therapy is different from that of the experimental intervention.

    If we use μ1and μ2to represent the cure rates of the standard therapy and the experimental intervention,the H0and H1can be quantitatively expressed as: Null hypothesis (H0): μ1- μ2= 0 (no difference) vs. Alternative hypothesis (H1): μ1- μ2≠ 0 (difference)

    Of course, our alternative hypothesis should be stated as μ1<μ2, if we are sure that μ1>μ2will not happen. Such one-sided alternative increases power for the same sample size. If we already have data, we can easily test the above hypotheses[6]. Hypothesis testing in clinical trials is analogous to trials by juries in court cases in which the null hypothesis is that a defendant is presumed innocent, while the alternative hypothesis is that the defendant is proven guilty. Our inference of rejecting the null and accepting the alternative hypothesis at type I error α = 0.05 corresponds to a judicial decision that finds the defendant guilty beyond reasonable doubt. Likewise, a non-conviction decision frees the defendant, it does not imply that the defendant truly does not commit the prosecuted crime, but rather only indicates that there is not enough evidence for the conviction. Therefore, we have two types of errors in making the decision. The type I error or false positive alpha (α) refers to the error in convicting the innocent or, in a clinical trial, conclude the treatments differ, when, in fact, they are the same.The type II error or false negative beta (β) is the error in freeing the guilty or failing to conclude the treatments differ, when, in fact, they are different. In statistics,we often use 1-β, or statistical power, which is the probability for statistically detecting difference when true difference exists. We must control or minimize both types of errors or have small false positive rate and high power for a credible trial. High proportion of early published negative trials did not have adequate power due to small sample sizes and Freiman et al.[7]showed that 50 of 71 negative trials that they had surveyed could miss a 50% benefit. We need a sample size large enough to have small false positive rate and high power in detecting the difference for the primary outcome.

    3. Sample size

    Sample size for hypothesis testing of the primary question is a function of the type I error rate or significance level (usually 0.05 or smaller), power (1-β,80% or larger), minimal clinically significant difference in primary outcome by treatments (set by investigators),and measure of variability (usually from pilot or related studies) in primary outcome. Suppose we have a continuous response variable from 2 independent samples for testing H0: μ1- μ2= 0 vs. H1: μ1- μ2≠ 0, 2-sided alternative. Our total sample size[8]is

    where N=2N1=2N2(N1and N2are corresponding group sample sizes), Zais critical value corresponding to 2-sided, Type I error rate, Zbis critical value corresponding to Type II error rate, d is effect size or the minimal detectable difference, and s is the standard deviation for the primary outcome. We can see the relationship among sample size, power (Type II error),Type I error, effect size, and standard deviation. Often we may not have any estimate for effect size d and standard deviation s. Cohen defines

    as standardized effect size (SES) when outcome standard deviation estimates are not available[9]. Then the formula for total sample size becomes

    The SES is widely used to guide power analysis, with the general guideline: small effect size, SES=0.2, medium effect size, SES=0.5, and large effect size, SES=0.8. We may use this guideline for estimating our sample size accordingly if we do not have any preliminary data.

    4. Equivalent test and other extensions

    Another popular type of hypothesis testing is equivalence. The new treatment may not be better than the standard, but offers other benefits, such as cost saving, fewer side effects, or easier to administer, etc. In such a study, the hypotheses are set as following:

    Null hypothesis: Cure rate for new treatment is worse than that for standard therapy.

    Alternative hypothesis: Cure rate for new treatment is“clinically equivalent” to that for standard therapy:

    Null hypothesis: |μ1 - μ2| > Δ vs Alternative hypothesis:|μ1 - μ2| ≤ Δ

    where Δ is a minimum clinically-meaningful difference.Note here that Δ is defined by clinicians according to their experience and not by any statistical methods.Please see[10]for a recent example on equivalent test of thrombolytic therapy for acute ischemic stroke.

    Readers are referred to[8]for methods of sample size calculations for testing different kinds of hypotheses.Also see[11]for advanced topics on testing statistical hypotheses.

    In many studies, we often continuously monitor the trials for important differences in toxicity among treatments, for “definitive” differences in outcome among treatments, and/or for unlikely important differences. The goal of interim analyses is to assess the need to stop study early for severe side effects,efficacy, or futility, or to modify protocol (which belongs to adaptive design). Theoretically, we may have as many interim analyses as we want. But the more interim analyses we perform at say α =0.05, the more likely we declare “statistical significance”, increasing the type I error. So we need to adjust our significance level according to the number of interim analyses performed. Please see[12]for statistical techniques on such adjustments. In practice, interim analyses are quite costly, with 2 or 3 interim analyses more popular than 5 or 6. Interim analyses are common for studies with high risk treatments such as cancer, especially in Children’s Oncology Group (COG) studies[13,14].

    In this report, we have discussed components of traditional clinical trials, in which primary question and hypotheses do not change during the process of the trial. But the scenario is different in modern adaptive designs. ‘An adaptive design is referred to as a clinical trial design that uses accumulating data to decide on how to modify aspects of the study as it continues,without undermining the validity and integrity of the trial’[15]. The FDA’s definition is ‘An adaptive design for a medical device clinical study is defined as a clinical trial design that allows for prospectively planned modifications based on accumulating study data without undermining the trial’s integrity and validity’[16]. An adaptation is defined as a change or modification made to a clinical trial before and during the conduct of the study. Examples include relax inclusion/exclusion criteria, change study endpoints, modify dose and treatment duration, change primary question, change hypotheses etc.[17]. For Bayesian approach of adaptive design, please see[18].

    Funding

    Not available.

    Conflict of interest statement

    The authors report no conflict of interest

    Acknowledgement

    Thanks are given to the two anonymous editors for their valuable comments.

    Reference

    1. Burger JA, Tedeschi A, Barr PM, Robak T, Owen C, Ghia P,et al. Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. N Engl J Med. 2015; 373(25): 2425-2437. doi: http://dx.doi.org/10.1056/NEJMoa1509388

    2. Steering Committee of the Physicains’ Health Study Research Group. Final report on the aspirin component of the ongoing physicians’ health study. N Engl J Med. 1989; 321(3): 129-135. doi: http://dx.doi.org/10.1056/NEJM198907203210301

    3. Friedman LM, Furberg CD, DeMets DL. Fundamentals of Clinical trials, 4thEd. New York; 2010

    4. Meinert CL. Clinical Trials: Design, Conduct, and Analysis.New York: Oxford University Press; 2012

    5. Lehmann EL. The fisher, neyman-pearson theories of testing hypotheses: One theory or two? J Am Stat Assoc. 1993;88(424): 1242-1249. doi: http://dx.doi.org/10.1080/016214 59.1993.10476404

    6. van Belle G, Fisher LD, Heagerty PJ, Lumley T. Biostatistics: a Methodology for Health Sciences, 2ndEd. New Jersey: Wiley& Sons, Hoboken; 2004

    7. Freiman JA, Chalmers TC, Smith Jr.H, Kuebler RR. The Importance of Beta, the Type II Error and sample size in the design and interpretation of the randomized control trial — survey of 71 negative trials. N Engl J Med.1978; 299(3): 690-694. doi: http://dx.doi.org/10.1056/NEJM197809282991304

    8. Chow S, Shao J, Wang H. Sample Size Calculations in Clinical Researches. New York: Marcel Dekker; 2003

    9. Cohen J. A power primer. Psychol Bull. 1992; 112(1): 155-159. doi: http://dx.doi.org/10.1037/0033-2909.112.1.155

    10. Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM,Lee TH, et al. Low-dose versus standard-dose intravenous Alteplase in acute ischemic stroke. N Engl J Med. 2016;374(24): 2313-2323. doi: http://dx.doi.org/10.1056/NEJMoa1515510

    11. Lehmann EL. Testing Statistical Hypotheses, 2ndEd. New York: Springer; 1986

    12. Jennison C, Turnbull BW. Group sequential methods with applications to clinical trials. Boca Raton, FL: Chapman &Hall/CRC; 1999

    13. Malempati S, Hawkins DS. Rhabdomyosarcoma: Review of the Children’s Oncology Group (COG) Soft-Tissue Sarcoma Committee Experience and Rationale for Current COG Studies. Pediatri Blood Cancer. 2012; 59(1): 5-10. doi:http://dx.doi.org/10.1002/pbc.24118

    14. Rudzinski ER, Anderson JR, Hawkins DS, Skapek SX, Parham DM, Teot LA. The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma:A Report from the Children’s Oncology Group. Arch Pathol Lab Med. 2015; 139(10): 1281-1287. doi: http://dx.doi.org/10.5858/arpa.2014-0475-OA

    15. Gallo P, Chow CS, Dragalin V, Gaydos B, Krams M, Pinheiro J.Adaptive designs in clinical drug development—an executive summary of the PhRMA working group. J Biopharm Stat.2006; 16(3): 275-283

    16. FDA. Adaptive Designs for Medical Device Clinical Studies:Draft Guidance. FDA; 2015 [cited 2016]. Available from: http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm446729.pdf

    17. Chow SC, Chang M. Adaptive Design Methods in Clinical Trials. Boca Raton, FL: Chapman & Hall/CRC; 2007

    18. Berry SM, Carlin BP, Lee JJ, Muller P. Bayesian Adaptive Design. Boca Raton, FL: Chapman & Hall/CRC; 2010

    Dr. Jiangtao Luo obtained his PhD degree from the University of Florida in 2009. He started to work at the University of Nebraska Medical Center College of Public Health, USA in 2010, and is currently an assistant professor in the Department of Biostatistics. His research interests include design of medical studies, statistical genetics, Bayesian method, numerical optimization, and big data.

    隨機(jī)對照臨床試驗(yàn)中的主要問題和假設(shè)檢驗(yàn)

    Jiangtao LUO

    假設(shè)、隨機(jī)、臨床試驗(yàn)、主要問題

    We briefly reviewed and provided cautions about some of the fundamental concepts used in the design of medical and public studies, especially primary question, hypothesis testing and sample size in this short note. We also talked about some of the extensions and development in the recent years.

    [Shanghai Arch Psychiatry. 2016; 28(3): 177-180.

    http://dx.doi.org/10.11919/j.issn.1002-0829.216057]

    Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198-4375 USA

    correspondence: Luo Jiangtao. Mailing address: Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, 984375 Nebraska Medical Center, Omaha, NE 68198-4375 USA. Postcode: NE 68198-4375 USA. E-mail: Jiangtao.luo@unmc.edu

    概述:本文中我們簡要地回顧并提供了醫(yī)療和公共研究設(shè)計(jì)中使用的一些基本概念的有關(guān)注意事項(xiàng),特別是主要問題、假設(shè)檢驗(yàn)、和樣本量。此外,我們還討論了最近幾年的一些擴(kuò)展和發(fā)展。

    猜你喜歡
    假設(shè)檢驗(yàn)樣本量臨床試驗(yàn)
    醫(yī)學(xué)研究中樣本量的選擇
    抗疫中第一個(gè)獲批臨床試驗(yàn)的中藥——說說化濕敗毒方
    假設(shè)檢驗(yàn)結(jié)果的對立性分析
    航空裝備測試性試驗(yàn)樣本量確定方法
    Sample Size Calculations for Comparing Groups with Binary Outcomes
    統(tǒng)計(jì)推斷的研究
    雙冪變換下正態(tài)線性回歸模型參數(shù)的假設(shè)檢驗(yàn)
    統(tǒng)計(jì)學(xué)教學(xué)中關(guān)于假設(shè)檢驗(yàn)問題探討
    自適應(yīng)樣本量調(diào)整中Fisher合并P值法和傳統(tǒng)檢驗(yàn)法的模擬比較
    腫瘤治療藥物Tosedostat的Ⅱ期臨床試驗(yàn)結(jié)束
    91成人精品电影| 丰满迷人的少妇在线观看| 50天的宝宝边吃奶边哭怎么回事| 曰老女人黄片| 欧美+亚洲+日韩+国产| 18禁国产床啪视频网站| 欧美精品人与动牲交sv欧美| 国产男女内射视频| 一本综合久久免费| 丁香六月天网| 在线天堂中文资源库| 男女边摸边吃奶| 少妇的丰满在线观看| 国产1区2区3区精品| 天堂俺去俺来也www色官网| 美女午夜性视频免费| 女人久久www免费人成看片| 黄片大片在线免费观看| 亚洲国产中文字幕在线视频| 下体分泌物呈黄色| 黄网站色视频无遮挡免费观看| 国产亚洲一区二区精品| 妹子高潮喷水视频| 丰满饥渴人妻一区二区三| 欧美日韩黄片免| 热re99久久精品国产66热6| 精品卡一卡二卡四卡免费| 可以免费在线观看a视频的电影网站| 国产97色在线日韩免费| 免费av中文字幕在线| 我的亚洲天堂| 热99国产精品久久久久久7| 国产精品98久久久久久宅男小说| 9热在线视频观看99| 欧美日韩国产mv在线观看视频| 九色亚洲精品在线播放| 亚洲精品国产区一区二| 成人国产一区最新在线观看| 丝袜喷水一区| 人人妻人人爽人人添夜夜欢视频| 黄色视频不卡| 久久人妻福利社区极品人妻图片| 视频在线观看一区二区三区| 日本wwww免费看| 18禁黄网站禁片午夜丰满| 国产单亲对白刺激| 久久久国产一区二区| 国产高清videossex| 亚洲黑人精品在线| 亚洲精华国产精华精| 久久中文字幕人妻熟女| 51午夜福利影视在线观看| 最新在线观看一区二区三区| 美国免费a级毛片| 欧美+亚洲+日韩+国产| 一本一本久久a久久精品综合妖精| 老司机影院毛片| 日韩成人在线观看一区二区三区| 丝瓜视频免费看黄片| 99久久人妻综合| 在线观看免费视频网站a站| 久久久水蜜桃国产精品网| 俄罗斯特黄特色一大片| 桃红色精品国产亚洲av| 成人国语在线视频| 人人澡人人妻人| 超碰成人久久| 12—13女人毛片做爰片一| 国产成人系列免费观看| 99re6热这里在线精品视频| 久久国产精品大桥未久av| 女性生殖器流出的白浆| 丝袜美腿诱惑在线| 纵有疾风起免费观看全集完整版| 久久天躁狠狠躁夜夜2o2o| 99国产精品一区二区蜜桃av | 大陆偷拍与自拍| 亚洲国产av新网站| 欧美精品啪啪一区二区三区| 热99久久久久精品小说推荐| 香蕉国产在线看| 91大片在线观看| 国产日韩欧美视频二区| 黄色视频不卡| 亚洲人成伊人成综合网2020| 老司机亚洲免费影院| 12—13女人毛片做爰片一| 嫩草影视91久久| 久久久久久久久久久久大奶| 欧美日韩福利视频一区二区| 波多野结衣一区麻豆| 法律面前人人平等表现在哪些方面| 91大片在线观看| 制服人妻中文乱码| 久热爱精品视频在线9| 久久婷婷成人综合色麻豆| 另类亚洲欧美激情| 亚洲欧美一区二区三区黑人| 国产精品成人在线| 男女免费视频国产| 麻豆成人av在线观看| 少妇精品久久久久久久| 国产亚洲午夜精品一区二区久久| 亚洲av日韩在线播放| av欧美777| 国产精品亚洲一级av第二区| 青青草视频在线视频观看| 18在线观看网站| 激情在线观看视频在线高清 | 热99re8久久精品国产| 黄频高清免费视频| 99re6热这里在线精品视频| 九色亚洲精品在线播放| 免费在线观看视频国产中文字幕亚洲| 一级毛片精品| 中文字幕色久视频| 亚洲国产欧美在线一区| av一本久久久久| 亚洲欧美日韩高清在线视频 | 国产淫语在线视频| 国产91精品成人一区二区三区 | 国产在线精品亚洲第一网站| 免费久久久久久久精品成人欧美视频| 亚洲综合色网址| 亚洲国产av影院在线观看| 国产极品粉嫩免费观看在线| 国产成人一区二区三区免费视频网站| 18在线观看网站| 亚洲精品美女久久久久99蜜臀| 亚洲专区中文字幕在线| 美女扒开内裤让男人捅视频| 久久中文字幕一级| 亚洲三区欧美一区| 免费在线观看日本一区| 免费观看a级毛片全部| 女人被躁到高潮嗷嗷叫费观| 大香蕉久久网| 日韩欧美国产一区二区入口| 2018国产大陆天天弄谢| 一区二区三区精品91| 国产欧美日韩一区二区三| a级毛片黄视频| av网站在线播放免费| 老汉色av国产亚洲站长工具| 亚洲成人国产一区在线观看| 亚洲欧美激情在线| 久久ye,这里只有精品| 日韩熟女老妇一区二区性免费视频| 悠悠久久av| 久久午夜综合久久蜜桃| 亚洲精品自拍成人| 欧美人与性动交α欧美软件| 无人区码免费观看不卡 | 免费在线观看黄色视频的| 99在线人妻在线中文字幕 | 免费观看a级毛片全部| 日本精品一区二区三区蜜桃| 动漫黄色视频在线观看| 三级毛片av免费| 国产免费现黄频在线看| 搡老岳熟女国产| 久久久久久人人人人人| 久久影院123| 丝瓜视频免费看黄片| 丰满少妇做爰视频| 多毛熟女@视频| 又大又爽又粗| 久久久久精品人妻al黑| 一区福利在线观看| 丝袜在线中文字幕| 手机成人av网站| 91精品国产国语对白视频| 久久精品国产99精品国产亚洲性色 | 999久久久精品免费观看国产| 九色亚洲精品在线播放| 两个人看的免费小视频| 高清av免费在线| 国产成人av教育| 国产熟女午夜一区二区三区| 在线观看免费午夜福利视频| 视频区图区小说| 免费人妻精品一区二区三区视频| 亚洲五月婷婷丁香| 中文欧美无线码| 久久这里只有精品19| 色综合欧美亚洲国产小说| www.熟女人妻精品国产| 国产精品久久电影中文字幕 | 亚洲成人手机| 午夜福利在线观看吧| 国产高清视频在线播放一区| 一区二区三区乱码不卡18| 91av网站免费观看| 老司机靠b影院| 婷婷丁香在线五月| 久久av网站| av不卡在线播放| 看免费av毛片| 欧美日韩中文字幕国产精品一区二区三区 | 欧美变态另类bdsm刘玥| 国产精品1区2区在线观看. | 热re99久久精品国产66热6| 啦啦啦中文免费视频观看日本| 一本色道久久久久久精品综合| 老汉色∧v一级毛片| 亚洲天堂av无毛| 亚洲,欧美精品.| 亚洲av片天天在线观看| 欧美日韩亚洲综合一区二区三区_| 国产精品一区二区精品视频观看| 999久久久国产精品视频| 成人免费观看视频高清| 麻豆国产av国片精品| 久久人人爽av亚洲精品天堂| 欧美精品亚洲一区二区| 亚洲av日韩精品久久久久久密| 国产精品偷伦视频观看了| 一本色道久久久久久精品综合| 中文字幕高清在线视频| 老汉色∧v一级毛片| kizo精华| 精品欧美一区二区三区在线| 亚洲伊人色综图| a级毛片在线看网站| 国产成人免费无遮挡视频| 国产男靠女视频免费网站| 最近最新免费中文字幕在线| 精品少妇内射三级| 久久久欧美国产精品| 成人手机av| 欧美日韩亚洲综合一区二区三区_| 国产精品久久久久久精品古装| 成人特级黄色片久久久久久久 | 国产在线一区二区三区精| 十八禁网站网址无遮挡| 最近最新中文字幕大全免费视频| 国产成人免费观看mmmm| 午夜91福利影院| 女人被躁到高潮嗷嗷叫费观| 日韩欧美一区二区三区在线观看 | 亚洲成人国产一区在线观看| 国产精品九九99| 热99re8久久精品国产| 一级黄色大片毛片| 国产伦人伦偷精品视频| 精品国产国语对白av| 亚洲欧美色中文字幕在线| 如日韩欧美国产精品一区二区三区| 女人爽到高潮嗷嗷叫在线视频| 欧美精品一区二区免费开放| 亚洲va日本ⅴa欧美va伊人久久| 欧美激情 高清一区二区三区| 国产欧美日韩综合在线一区二区| 欧美乱码精品一区二区三区| 99re6热这里在线精品视频| 精品欧美一区二区三区在线| 中文字幕制服av| 日韩人妻精品一区2区三区| 99精品在免费线老司机午夜| 亚洲第一青青草原| 成人三级做爰电影| 丝袜喷水一区| 69精品国产乱码久久久| 美女国产高潮福利片在线看| 99国产综合亚洲精品| 高清在线国产一区| 成人国产一区最新在线观看| 国产精品偷伦视频观看了| 岛国在线观看网站| 日韩三级视频一区二区三区| 午夜久久久在线观看| 嫩草影视91久久| 男女下面插进去视频免费观看| 亚洲精品av麻豆狂野| 美女午夜性视频免费| 69精品国产乱码久久久| 热re99久久精品国产66热6| cao死你这个sao货| 午夜91福利影院| 久久久久精品人妻al黑| 精品一区二区三区av网在线观看 | 一级片免费观看大全| 99精品在免费线老司机午夜| 亚洲久久久国产精品| 国产区一区二久久| 亚洲成人免费电影在线观看| 国内毛片毛片毛片毛片毛片| 啦啦啦在线免费观看视频4| 91字幕亚洲| 久久免费观看电影| 久久精品亚洲精品国产色婷小说| 少妇精品久久久久久久| 久久久国产精品麻豆| 久久这里只有精品19| 男男h啪啪无遮挡| 欧美精品亚洲一区二区| 免费在线观看影片大全网站| 人人妻,人人澡人人爽秒播| 91av网站免费观看| 色综合欧美亚洲国产小说| 女性被躁到高潮视频| 99久久人妻综合| 露出奶头的视频| 国产极品粉嫩免费观看在线| 午夜91福利影院| 亚洲精品在线美女| 亚洲精品美女久久av网站| 人成视频在线观看免费观看| 在线播放国产精品三级| 精品国产超薄肉色丝袜足j| 日韩三级视频一区二区三区| 一区二区av电影网| 久久国产亚洲av麻豆专区| 亚洲av成人不卡在线观看播放网| 国产精品.久久久| 99久久国产精品久久久| 丰满少妇做爰视频| av欧美777| 怎么达到女性高潮| 午夜视频精品福利| 黄频高清免费视频| 欧美大码av| 少妇粗大呻吟视频| 成人亚洲精品一区在线观看| 久久久久视频综合| 欧美日韩精品网址| 深夜精品福利| 国产欧美日韩综合在线一区二区| 国产亚洲精品一区二区www | 国产在线一区二区三区精| 欧美激情高清一区二区三区| 黑人猛操日本美女一级片| 黄网站色视频无遮挡免费观看| 在线天堂中文资源库| 99热网站在线观看| 777久久人妻少妇嫩草av网站| 欧美激情 高清一区二区三区| 热99re8久久精品国产| 在线 av 中文字幕| 欧美+亚洲+日韩+国产| 天天操日日干夜夜撸| 中文字幕av电影在线播放| 精品人妻1区二区| 18禁美女被吸乳视频| 欧美激情极品国产一区二区三区| 精品一区二区三区四区五区乱码| 亚洲色图综合在线观看| 波多野结衣av一区二区av| 中国美女看黄片| 丰满少妇做爰视频| 国产精品免费一区二区三区在线 | 一本久久精品| 精品国产一区二区三区四区第35| 中文字幕人妻熟女乱码| 国产老妇伦熟女老妇高清| 亚洲精品一二三| 女警被强在线播放| 欧美国产精品va在线观看不卡| 日韩 欧美 亚洲 中文字幕| 免费观看av网站的网址| 午夜久久久在线观看| 变态另类成人亚洲欧美熟女 | 欧美精品一区二区免费开放| 国产99久久九九免费精品| 午夜免费成人在线视频| 中文字幕另类日韩欧美亚洲嫩草| 久久久国产一区二区| 侵犯人妻中文字幕一二三四区| 国产一区二区激情短视频| 人人妻人人添人人爽欧美一区卜| 天堂动漫精品| 真人做人爱边吃奶动态| 一个人免费在线观看的高清视频| 天天躁日日躁夜夜躁夜夜| 久久人妻福利社区极品人妻图片| 无限看片的www在线观看| 91av网站免费观看| 久久久久网色| 日韩人妻精品一区2区三区| 一级a爱视频在线免费观看| 欧美精品人与动牲交sv欧美| 国产精品1区2区在线观看. | 久久久久久亚洲精品国产蜜桃av| 日本欧美视频一区| 国产男女内射视频| 欧美变态另类bdsm刘玥| 黄片播放在线免费| 美女高潮到喷水免费观看| 色视频在线一区二区三区| 亚洲精品美女久久av网站| 日日爽夜夜爽网站| 精品国产一区二区三区久久久樱花| 亚洲av成人一区二区三| 欧美日韩亚洲综合一区二区三区_| 久久精品亚洲精品国产色婷小说| 久久久久久久精品吃奶| 国产精品亚洲一级av第二区| 亚洲天堂av无毛| 日韩免费av在线播放| 久久这里只有精品19| 十八禁高潮呻吟视频| 99久久精品国产亚洲精品| 一个人免费看片子| 欧美一级毛片孕妇| 热99久久久久精品小说推荐| 国产精品一区二区在线不卡| 99国产精品免费福利视频| 亚洲欧美日韩高清在线视频 | 免费在线观看视频国产中文字幕亚洲| 精品福利永久在线观看| 日韩中文字幕欧美一区二区| 成年人黄色毛片网站| 热re99久久精品国产66热6| 69精品国产乱码久久久| 新久久久久国产一级毛片| 精品久久蜜臀av无| 国产精品香港三级国产av潘金莲| 精品午夜福利视频在线观看一区 | 成年女人毛片免费观看观看9 | 午夜福利欧美成人| 免费久久久久久久精品成人欧美视频| 国产精品免费一区二区三区在线 | 精品国产国语对白av| 亚洲av日韩精品久久久久久密| 天天躁日日躁夜夜躁夜夜| 亚洲精品中文字幕一二三四区 | 国产av又大| 欧美精品亚洲一区二区| 欧美乱妇无乱码| 亚洲欧美日韩另类电影网站| 美女主播在线视频| 免费黄频网站在线观看国产| 丰满人妻熟妇乱又伦精品不卡| 考比视频在线观看| 国产aⅴ精品一区二区三区波| avwww免费| 久久久久国产一级毛片高清牌| 国产亚洲av高清不卡| 久久久久久免费高清国产稀缺| 黄色视频不卡| 成人国产av品久久久| 天堂俺去俺来也www色官网| 亚洲精品成人av观看孕妇| 黄频高清免费视频| 国产精品1区2区在线观看. | 日韩一卡2卡3卡4卡2021年| 色在线成人网| 亚洲综合色网址| 久久天堂一区二区三区四区| 日日摸夜夜添夜夜添小说| 国产av精品麻豆| 超碰成人久久| 亚洲人成电影观看| 老司机靠b影院| 99久久精品国产亚洲精品| 国产在线一区二区三区精| 菩萨蛮人人尽说江南好唐韦庄| 精品亚洲成a人片在线观看| 精品国产一区二区久久| 国产成人欧美| 99热国产这里只有精品6| 亚洲专区中文字幕在线| 欧美一级毛片孕妇| 久久av网站| 日日夜夜操网爽| 午夜福利在线免费观看网站| 下体分泌物呈黄色| 免费观看a级毛片全部| 免费看a级黄色片| 成人国产av品久久久| √禁漫天堂资源中文www| kizo精华| 亚洲av片天天在线观看| 欧美精品人与动牲交sv欧美| 免费在线观看影片大全网站| 一本色道久久久久久精品综合| 久久精品国产亚洲av香蕉五月 | 黄色 视频免费看| 亚洲国产av新网站| 天堂8中文在线网| 在线天堂中文资源库| 日韩免费高清中文字幕av| 亚洲黑人精品在线| 久久久久久免费高清国产稀缺| 精品一区二区三区四区五区乱码| 久久亚洲精品不卡| 丁香六月欧美| 天堂中文最新版在线下载| 亚洲欧美精品综合一区二区三区| 波多野结衣一区麻豆| 精品人妻1区二区| 国产亚洲午夜精品一区二区久久| 啦啦啦 在线观看视频| 亚洲自偷自拍图片 自拍| 最近最新免费中文字幕在线| 999久久久国产精品视频| 91麻豆av在线| 精品人妻熟女毛片av久久网站| 国产亚洲精品一区二区www | svipshipincom国产片| 亚洲精品美女久久av网站| 欧美人与性动交α欧美软件| 成人手机av| 国产亚洲精品第一综合不卡| 男女高潮啪啪啪动态图| 国产欧美日韩精品亚洲av| 精品国产国语对白av| 中亚洲国语对白在线视频| 国产欧美日韩一区二区三区在线| av网站在线播放免费| www.999成人在线观看| 成人永久免费在线观看视频 | 999久久久国产精品视频| 午夜激情久久久久久久| 国产精品二区激情视频| 国产精品久久久久成人av| 国产精品偷伦视频观看了| 新久久久久国产一级毛片| 伦理电影免费视频| 国产一区二区三区在线臀色熟女 | 夜夜骑夜夜射夜夜干| 免费看十八禁软件| 亚洲国产欧美日韩在线播放| 桃花免费在线播放| 久久精品aⅴ一区二区三区四区| 国产精品一区二区在线不卡| 国产av精品麻豆| 麻豆乱淫一区二区| 国产区一区二久久| 欧美黄色片欧美黄色片| 夜夜骑夜夜射夜夜干| 国产精品偷伦视频观看了| 亚洲全国av大片| 夫妻午夜视频| 五月开心婷婷网| 亚洲午夜理论影院| 亚洲人成电影观看| 免费黄频网站在线观看国产| 人人澡人人妻人| 人妻一区二区av| 91九色精品人成在线观看| 最近最新免费中文字幕在线| 日韩欧美国产一区二区入口| 美女扒开内裤让男人捅视频| 女性生殖器流出的白浆| 色老头精品视频在线观看| av福利片在线| 两个人免费观看高清视频| 日本av手机在线免费观看| 国产有黄有色有爽视频| 不卡一级毛片| 一级片'在线观看视频| 国产在线免费精品| 老熟妇乱子伦视频在线观看| av福利片在线| 人妻 亚洲 视频| 真人做人爱边吃奶动态| 中国美女看黄片| 新久久久久国产一级毛片| 丰满迷人的少妇在线观看| 狠狠婷婷综合久久久久久88av| 国产精品久久久久久精品古装| 婷婷丁香在线五月| 国产亚洲欧美在线一区二区| 在线观看66精品国产| 亚洲成a人片在线一区二区| 欧美午夜高清在线| 欧美日韩国产mv在线观看视频| 免费看十八禁软件| 免费黄频网站在线观看国产| 日本av手机在线免费观看| 交换朋友夫妻互换小说| 丝袜在线中文字幕| 午夜成年电影在线免费观看| 欧美日韩中文字幕国产精品一区二区三区 | 免费看a级黄色片| 国产在线精品亚洲第一网站| 国产伦人伦偷精品视频| 久久久久久久大尺度免费视频| 777米奇影视久久| 国产亚洲欧美在线一区二区| 在线观看免费视频日本深夜| 色婷婷av一区二区三区视频| 日本精品一区二区三区蜜桃| 亚洲午夜精品一区,二区,三区| 国产成人一区二区三区免费视频网站| av视频免费观看在线观看| av电影中文网址| 久久久国产成人免费| 国产av一区二区精品久久| 王馨瑶露胸无遮挡在线观看| 久久性视频一级片| 男女无遮挡免费网站观看| 国产1区2区3区精品| av超薄肉色丝袜交足视频| av线在线观看网站| 91大片在线观看| 黄频高清免费视频| 亚洲全国av大片| 欧美大码av| 高清黄色对白视频在线免费看| 纯流量卡能插随身wifi吗| 国产高清国产精品国产三级| 香蕉丝袜av| 久久久久久久国产电影| www.熟女人妻精品国产| 狠狠婷婷综合久久久久久88av| 国产欧美日韩一区二区三区在线| 久久ye,这里只有精品| 亚洲精品中文字幕一二三四区 | 国产男女内射视频| 极品教师在线免费播放| 女人被躁到高潮嗷嗷叫费观| 亚洲欧洲精品一区二区精品久久久| 99精国产麻豆久久婷婷|